Ross River virus disease clinical presentation, pathogenesis and current therapeutic strategies
Authors:
- 1 November 2017
- journal article
- review article
- Published by Elsevier in Microbes and Infection
- Vol. 19 (11) , 496-504
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Methotrexate Treatment Causes Early Onset of Disease in a Mouse Model of Ross River Virus-Induced Inflammatory Disease through Increased Monocyte ProductionPLOS ONE, 2013
- A Tyrosine-to-Histidine Switch at Position 18 of the Ross River Virus E2 Glycoprotein Is a Determinant of Virus Fitness in Disparate HostsJournal of Virology, 2013
- Myd88-Dependent Toll-Like Receptor 7 Signaling Mediates Protection from Severe Ross River Virus-Induced Disease in MiceJournal of Virology, 2012
- Interferon Response Factors 3 and 7 Protect against Chikungunya Virus Hemorrhagic Fever and ShockJournal of Virology, 2012
- Critical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositisProceedings of the National Academy of Sciences, 2011
- Identification and Characterization of a Ross River Virus Variant That Grows Persistently in Macrophages, Shows Altered Disease Kinetics in a Mouse Model, and Exhibits Resistance to Type I InterferonJournal of Virology, 2011
- Control of RSV-induced lung injury by alternatively activated macrophages is IL-4Rα-, TLR4-, and IFN-β-dependentMucosal Immunology, 2010
- Ross River Virus Envelope Glycans Contribute to Type I Interferon Production in Myeloid Dendritic CellsJournal of Virology, 2008
- Complement Contributes to Inflammatory Tissue Destruction in a Mouse Model of Ross River Virus-Induced DiseaseJournal of Virology, 2007
- Differential Induction of Type I Interferon Responses in Myeloid Dendritic Cells by Mosquito and Mammalian-Cell-Derived AlphavirusesJournal of Virology, 2007